A PYMNTS Company

Americas: Pharma’s $438M deal extends Bristol-Myers drugs to Latin America

By  |  February 12, 2013

New York-based pharmaceutical giant Bristol-Myers Squibb has reportedly signed a deal worth $438 million with Reckitt Benckiser, a personal health products company based in the UK. According to reports, the deal will last for three years an includes an agreement to a $44 million option fee, giving Reckitt the option of buying Bristol-Myers brands at the end of the three years. The contract gives Bristol-Myers control over Reckitt manufacturing and, in turn, allows Reckitt to sell Bristol-Myers medicines throughout Latin America, especially Mexico and Brazil. Mexico and Brazil antitrust authorities may review the deal, however.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

     

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Full Content: Fox News

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.